- RESEARCH HIGHLIGHT
- 30 April 2026
A biomarker shows which people with certain types of breast cancer are more likely to respond to an immune-based therapy.
Trending
- Targeting RBM41-mediated CKMT1B mRNA stability triggers disulfidptosis and suppresses tongue squamous cell carcinoma
- What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?
- RASolute-302 Data Signal a New Era for Pancreatic Cancer Drug Development
- FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer
- Tumor plasticity in macrophage niches promotes dormancy, EMT and chemoresistance of non-small cell lung cancer stem cells
- Ex-Deputy Who Shot Sonya Massey Is Denied a Request for Medical Release From Prison
- Subcutaneous Amivantamab Receives FDA Priority Review in R/M HNSCC
- Cancer Screenings by Age: When to Get Screened for Cancer
Saturday, August 1
